article · Clinical Infectious Diseases

Xpert <i>My</i> <i>cobacterium tuberculosis</i>/Rifampicin–Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications

Bertin C Bisimwa
Sifa Byadunia
Jean B. Nachega
Robin M. Warren
Steven Callens
Rosette Nyota
John Metcalfe
Andreas H. Diacon
Nadia A. Sam‐Agudu
Andre Nyandwe Hamama Bulabula
Maunank Shah
Freddy Birembano
Esto Bahizire
Marcel Yotebieng
Grant Theron
Michel Kaswa
Eric Mulume Musafiri
Patrick DMC Katoto
Jean-Paul Chirambiza
Zacharie Kashongwe

202021 citationsOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

In this high-risk MDR-TB study population, Xpert had low positive-predictive value for the presence of MDR-TB. Comprehensive resistance testing for both INH and RIF should be performed in this setting.

Research topics

Tuberculosis Research and Epidemiology
Mycobacterium research and diagnosis
Infectious Diseases and Tuberculosis

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1093/cid/ciaa873

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.